These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36243222)

  • 1. A homozygous truncating mutation of FGL2 is associated with immune dysregulation.
    Janssen E; Alosaimi MF; Alazami AM; Alsuliman A; Alaiya A; Al-Saud B; Al-Mousa H; Al-Zaid TJ; Smith E; Platt CD; Alruwaili H; Albanyan S; Al-Mayouf SM; Geha RS
    J Allergy Clin Immunol; 2023 Feb; 151(2):572-578.e1. PubMed ID: 36243222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
    Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.
    Shalev I; Liu H; Koscik C; Bartczak A; Javadi M; Wong KM; Maknojia A; He W; Liu MF; Diao J; Winter E; Manuel J; McCarthy D; Cattral M; Gommerman J; Clark DA; Phillips MJ; Gorczynski RR; Zhang L; Downey G; Grant D; Cybulsky MI; Levy G
    J Immunol; 2008 Jan; 180(1):249-60. PubMed ID: 18097026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis.
    Bartczak A; Zhang J; Adeyi O; Amir A; Grant D; Gorczynski R; Selzner N; Chruscinski A; Levy GA
    World J Gastroenterol; 2017 Apr; 23(15):2673-2684. PubMed ID: 28487604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
    Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A
    Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Follicular Regulatory Cell-Derived Fibrinogen-like Protein 2 Regulates Production of Autoantibodies and Induction of Systemic Autoimmunity.
    Sungnak W; Wagner A; Kowalczyk MS; Bod L; Kye YC; Sage PT; Sharpe AH; Sobel RA; Quintana FJ; Rozenblatt-Rosen O; Regev A; Wang C; Yosef N; Kuchroo VK
    J Immunol; 2020 Dec; 205(12):3247-3262. PubMed ID: 33168576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells.
    Chan CW; Kay LS; Khadaroo RG; Chan MW; Lakatoo S; Young KJ; Zhang L; Gorczynski RM; Cattral M; Rotstein O; Levy GA
    J Immunol; 2003 Apr; 170(8):4036-44. PubMed ID: 12682232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Fibrinogen-Like Protein 2 Promotes Tolerance in a Fully Mismatched Murine Model of Heart Transplantation.
    Bartczak A; Chruscinski A; Mendicino M; Liu H; Zhang J; He W; Amir AZ; Nguyen A; Khattar R; Sadozai H; Lobe CG; Adeyi O; Phillips MJ; Zhang L; Gorczynski RM; Grant D; Levy GA
    Am J Transplant; 2016 Jun; 16(6):1739-50. PubMed ID: 26718313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2.
    Liu H; Yang PS; Zhu T; Manuel J; Zhang J; He W; Shalev I; Zhang L; Cybulsky MI; Grant DR; Phillips MJ; Levy GA
    Int J Biochem Cell Biol; 2013 Feb; 45(2):408-18. PubMed ID: 23127799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
    Latha K; Yan J; Yang Y; Gressot LV; Kong LY; Manyam G; Ezhilarasan R; Wang Q; Sulman EP; Eric Davis R; Huang S; Fuller GN; Rao A; Heimberger AB; Li S; Rao G
    J Natl Cancer Inst; 2019 Mar; 111(3):292-300. PubMed ID: 29947810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
    Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
    Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity.
    Chruscinski A; Sadozai H; Rojas-Luengas V; Bartczak A; Khattar R; Selzner N; Levy GA
    Rambam Maimonides Med J; 2015 Jul; 6(3):. PubMed ID: 26241231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen-like protein 2: Its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors.
    Zhang S; Rao G; Heimberger A; Li S
    Cytokine Growth Factor Rev; 2023 Feb; 69():73-79. PubMed ID: 36085259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.
    Hu J; Yan J; Rao G; Latha K; Overwijk WW; Heimberger AB; Li S
    Int Rev Immunol; 2016 Jul; 35(4):325-339. PubMed ID: 25259408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
    Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
    J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
    Shalev I; Wong KM; Foerster K; Zhu Y; Chan C; Maknojia A; Zhang J; Ma XZ; Yang XC; Gao JF; Liu H; Selzner N; Clark DA; Adeyi O; Phillips MJ; Gorczynski RR; Grant D; McGilvray I; Levy G
    Hepatology; 2009 Feb; 49(2):387-97. PubMed ID: 19085958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
    Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
    PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated fibrinogen‑like protein 2 in TNBS‑induced colitis mice: Association with Th17 and regulatory T cells.
    Lin H; Chen R; Jiang X; Wu X; Huang X; Dong X; Yang X; Lin X; Chen X; Chen X; Huang Z
    Mol Med Rep; 2017 Sep; 16(3):3445-3454. PubMed ID: 28713999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2.
    Hancock WW; Szaba FM; Berggren KN; Parent MA; Mullarky IK; Pearl J; Cooper AM; Ely KH; Woodland DL; Kim IJ; Blackman MA; Johnson LL; Smiley ST
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3005-10. PubMed ID: 14976252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.